{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:04:42Z","timestamp":1772132682831,"version":"3.50.1"},"reference-count":148,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.bbagen.2008.09.002","type":"journal-article","created":{"date-parts":[[2008,9,21]],"date-time":"2008-09-21T13:32:26Z","timestamp":1222003946000},"page":"663-670","source":"Crossref","is-referenced-by-count":32,"title":["Co-factors in liver disease: The role of HFE-related hereditary hemochromatosis and iron"],"prefix":"10.1016","volume":"1790","author":[{"given":"Daniel F.","family":"Wallace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. Nathan","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2008.09.002_bib1","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1073\/pnas.95.5.2492","article-title":"HFE gene knockout produces mouse model of hereditary hemochromatosis","volume":"95","author":"Zhou","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2008.09.002_bib2","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1073\/pnas.162360699","article-title":"Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis","volume":"99","author":"Fleming","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2008.09.002_bib3","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/gut.2004.062018","article-title":"First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin","volume":"54","author":"Wallace","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.bbagen.2008.09.002_bib4","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1172\/JCI25049","article-title":"A mouse model of juvenile hemochromatosis","volume":"115","author":"Huang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2008.09.002_bib5","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1172\/JCI25683","article-title":"Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload","volume":"115","author":"Niederkofler","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2008.09.002_bib6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2006-02-003376","article-title":"Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis","volume":"108","author":"Lesbordes-Brion","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2008.09.002_bib7","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1182\/blood-2007-01-066068","article-title":"The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease","volume":"109","author":"Zohn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2008.09.002_bib8","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1073\/pnas.072632499","article-title":"Severe iron deficiency anemia in transgenic mice expressing liver hepcidin","volume":"99","author":"Nicolas","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2008.09.002_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1053\/j.gastro.2006.11.028","article-title":"Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload","volume":"132","author":"Wallace","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cmet.2007.11.014","article-title":"Hfe acts in hepatocytes to prevent hemochromatosis","volume":"7","author":"Vujic Spasic","year":"2008","journal-title":"Cell. Metab."},{"key":"10.1016\/j.bbagen.2008.09.002_bib11","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1182\/blood-2006-07-036186","article-title":"Physiologic systemic iron metabolism in mice deficient for duodenal Hfe","volume":"109","author":"Vujic Spasic","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2008.09.002_bib12","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2008.09.002_bib13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI0215686","article-title":"The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation","volume":"110","author":"Nicolas","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2008.09.002_bib14","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2003-03-0953","article-title":"Effect of hepcidin on intestinal iron absorption in mice","volume":"103","author":"Laftah","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2008.09.002_bib15","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood-2005-04-1766","article-title":"Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs","volume":"106","author":"Rivera","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2008.09.002_bib16","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2008.09.002_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng0896-399","article-title":"A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis","volume":"13","author":"Feder","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbagen.2008.09.002_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/10906570050114902","article-title":"Geography of HFE C282Y and H63D mutations","volume":"4","author":"Merryweather-Clarke","year":"2000","journal-title":"Genet. Test"},{"key":"10.1016\/j.bbagen.2008.09.002_bib19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0002-9297(07)64339-0","article-title":"The significance of the 187G (H63D) mutation in hemochromatosis","volume":"61","author":"Beutler","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbagen.2008.09.002_bib20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1046\/j.1365-2141.2001.02949.x","article-title":"HFE mutations, iron deficiency and overload in 10,500 blood donors","volume":"114","author":"Jackson","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(02)07447-0","article-title":"Penetrance of 845G\u2192A (C282Y) HFE hereditary haemochromatosis mutation in the USA","volume":"359","author":"Beutler","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2008.09.002_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa073286","article-title":"Iron-overload-related disease in HFE hereditary hemochromatosis","volume":"358","author":"Allen","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2008.09.002_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng1053","article-title":"Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis","volume":"33","author":"Roetto","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbagen.2008.09.002_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng1274","article-title":"Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis","volume":"36","author":"Papanikolaou","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbagen.2008.09.002_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/75534","article-title":"The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22","volume":"25","author":"Camaschella","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbagen.2008.09.002_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/90038","article-title":"A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis","volume":"28","author":"Njajou","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbagen.2008.09.002_bib27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1172\/JCI200113468","article-title":"Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene","volume":"108","author":"Montosi","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2008.09.002_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcmd.2003.08.003","article-title":"The ferroportin disease","volume":"32","author":"Pietrangelo","year":"2004","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbagen.2008.09.002_bib29","first-page":"77","article-title":"Secondary iron overload disorders","volume":"35","author":"Bottomley","year":"1998","journal-title":"Semin. Hematol."},{"issue":"Suppl","key":"10.1016\/j.bbagen.2008.09.002_bib30","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1046\/j.1440-1746.17.s1.12.x","article-title":"Hereditary hemochromatosis and iron overload diseases","volume":"17","author":"Powell","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib31","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1182\/blood-2007-11-122374","article-title":"Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis","volume":"111","author":"Wood","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2008.09.002_bib32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0168-8278(97)80424-2","article-title":"Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy","volume":"26","author":"Ramm","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0168-8278(02)00444-0","article-title":"Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis","volume":"38","author":"Bridle","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib34","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM200011233432104","article-title":"Disease-related conditions in relatives of patients with hemochromatosis","volume":"343","author":"Bulaj","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2008.09.002_bib35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archinte.166.3.294","article-title":"Screening for hemochromatosis in asymptomatic subjects with or without a family history","volume":"166","author":"Powell","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbagen.2008.09.002_bib36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/00365520701245488","article-title":"Penetrance of the C28Y\/C282Y genotype of the HFE gene","volume":"42","author":"Asberg","year":"2007","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib37","first-page":"809","article-title":"The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major","volume":"91","author":"Kattamis","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbagen.2008.09.002_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0741-8329(03)00127-7","article-title":"Iron as a co-morbid factor in nonhemochromatotic liver disease","volume":"30","author":"Bonkovsky","year":"2003","journal-title":"Alcohol"},{"key":"10.1016\/j.bbagen.2008.09.002_bib39","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJM199612123352403","article-title":"Clinical and biochemical abnormalities in people heterozygous for hemochromatosis","volume":"335","author":"Bulaj","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2008.09.002_bib40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(97)22005-2","article-title":"Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations","volume":"349","author":"Beutler","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2008.09.002_bib41","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994","volume":"341","author":"Alter","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2008.09.002_bib42","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/gut.44.5.759","article-title":"Mechanisms of immune escape in viral hepatitis","volume":"44","author":"Rosenberg","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.bbagen.2008.09.002_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(97)07361-3","article-title":"Hepatitis C","volume":"351","author":"Di Bisceglie","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2008.09.002_bib44","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/0016-5085(92)90339-Z","article-title":"Measurements of iron status in patients with chronic hepatitis","volume":"102","author":"Di Bisceglie","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0168-8278(95)80108-1","article-title":"Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis","volume":"22","author":"Farinati","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib46","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00042737-199512000-00014","article-title":"Liver iron concentration in chronic viral hepatitis: a study of 98 patients","volume":"7","author":"Piperno","year":"1995","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib47","first-page":"986","article-title":"Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron","volume":"89","author":"Hayashi","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib48","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00535-005-1636-6","article-title":"Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection","volume":"40","author":"Kawamura","year":"2005","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib49","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1478-3231.2007.01449.x","article-title":"Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study","volume":"27","author":"Alexander","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.bbagen.2008.09.002_bib50","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00535-007-2095-z","article-title":"Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C","volume":"42","author":"Kato","year":"2007","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib51","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/gast.2002.30983","article-title":"Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein","volume":"122","author":"Okuda","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib52","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/hep.510270631","article-title":"Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C","volume":"27","author":"Smith","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000040991","article-title":"Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection?","volume":"102","author":"Martinelli","year":"2000","journal-title":"Acta Haematol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib54","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0168-8278(02)00305-7","article-title":"Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C","volume":"37","author":"Bonkovsky","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib55","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/gast.2003.50046","article-title":"Hepatitis C, iron status, and disease severity: relationship with HFE mutations","volume":"124","author":"Tung","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0168-8278(02)00415-4","article-title":"HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis","volume":"38","author":"Erhardt","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib57","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1309\/X4UH5Q68Q4J3GDNV","article-title":"Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course","volume":"124","author":"Corengia","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib58","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1872-034X.2007.00118.x","article-title":"HFE C282Y gene variant is a risk factor for the progression to decompensated liver disease in chronic viral hepatitis C subjects in the Czech population","volume":"37","author":"Pacal","year":"2007","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbagen.2008.09.002_bib59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0016-5085(99)70236-2","article-title":"The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C","volume":"116","author":"Kazemi-Shirazi","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib60","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0168-8278(99)80308-0","article-title":"Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions","volume":"31","author":"Hezode","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1096-9071(200001)60:1<21::AID-JMV4>3.0.CO;2-F","article-title":"Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis","volume":"60","author":"Negro","year":"2000","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib62","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.0106-9543.2002.01672.x","article-title":"Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection","volume":"22","author":"Distante","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.bbagen.2008.09.002_bib63","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gut.50.2.248","article-title":"The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C","volume":"50","author":"Thorburn","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bbagen.2008.09.002_bib64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2893.2003.00488.x","article-title":"Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C","volume":"11","author":"Lebray","year":"2004","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.bbagen.2008.09.002_bib65","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/j.gastro.2006.08.036","article-title":"Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C","volume":"131","author":"Bonkovsky","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib66","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1053\/j.gastro.2006.02.060","article-title":"Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein","volume":"130","author":"Furutani","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib67","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.gastro.2007.10.011","article-title":"Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription","volume":"134","author":"Nishina","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2119\/2006-00057.Fujita","article-title":"Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C","volume":"13","author":"Fujita","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbagen.2008.09.002_bib69","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/gut.33.11.1444","article-title":"Genetic predisposition to alcoholic liver disease","volume":"33","author":"Day","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.bbagen.2008.09.002_bib70","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.3748\/wjg.v13.i37.4925","article-title":"Role of alcohol in the regulation of iron metabolism","volume":"13","author":"Harrison-Findik","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib71","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2004.01.020","article-title":"The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia","volume":"126","author":"Ioannou","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib72","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/gast.1997.v112.pm9041250","article-title":"Hemosiderosis in cirrhosis: a study of 447 native livers","volume":"112","author":"Ludwig","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib73","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1478-3231.2005.01004.x","article-title":"Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis","volume":"25","author":"Eng","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.bbagen.2008.09.002_bib74","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.1840200608","article-title":"Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis","volume":"20","author":"Fargion","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib75","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hep.510230411","article-title":"Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings","volume":"23","author":"Adams","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib76","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/gast.2002.30992","article-title":"Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis","volume":"122","author":"Fletcher","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib77","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/aje\/kwg123","article-title":"Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation","volume":"158","author":"Scotet","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib78","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.cgh.2006.07.009","article-title":"The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis","volume":"4","author":"Walsh","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib79","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/gut.43.2.262","article-title":"Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease","volume":"43","author":"Grove","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.bbagen.2008.09.002_bib80","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1572-0241.2006.00439.x","article-title":"HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls","volume":"101","author":"Gleeson","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib81","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1572-0241.2002.05553.x","article-title":"HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma","volume":"97","author":"Lauret","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib82","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1080\/00365529850172430","article-title":"Heterozygosity of the haemochromatosis mutation, C282Y, does not influence susceptibility to alcoholic cirrhosis","volume":"33","author":"Frenzer","year":"1998","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib83","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1440-1746.2006.04519.x","article-title":"Hemochromatosis gene mutations, liver function tests and iron status in alcohol-dependent patients admitted for detoxification","volume":"22","author":"Robinson","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib84","first-page":"156","article-title":"C282Y and H63D mutations of HFE gene in patients with advanced alcoholic liver disease","volume":"93","author":"Ropero Gradilla","year":"2001","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"10.1016\/j.bbagen.2008.09.002_bib85","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1530-0277.2006.00275.x","article-title":"Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations","volume":"31","author":"Flanagan","year":"2007","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.bbagen.2008.09.002_bib86","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1530-0277.2006.00002.x","article-title":"Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease","volume":"30","author":"Bridle","year":"2006","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.bbagen.2008.09.002_bib87","doi-asserted-by":"crossref","first-page":"22974","DOI":"10.1074\/jbc.M602098200","article-title":"Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression","volume":"281","author":"Harrison-Findik","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2008.09.002_bib88","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/hep.21895","article-title":"Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol","volume":"46","author":"Harrison-Findik","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib89","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib90","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease","volume":"29","author":"Caldwell","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib91","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib92","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/j.1572-0241.2001.04052.x","article-title":"Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis","volume":"96","author":"Fargion","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib93","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.20023","article-title":"Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver","volume":"39","author":"Bugianesi","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib94","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0016-5085(98)70482-2","article-title":"Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis","volume":"114","author":"George","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib95","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0016-5085(99)70401-4","article-title":"Insulin resistance-associated hepatic iron overload","volume":"117","author":"Mendler","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib96","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/gast.2002.32403","article-title":"Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease","volume":"122","author":"Facchini","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib97","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1572-0241.2007.01192.x","article-title":"Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study","volume":"102","author":"Valenti","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib98","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(99)80032-4","article-title":"Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis","volume":"31","author":"Bonkovsky","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib99","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.21742","article-title":"HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis","volume":"46","author":"Nelson","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/jhep.2002.33892","article-title":"HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity","volume":"36","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib101","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1590\/S0100-879X2003000600009","article-title":"Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis","volume":"36","author":"Deguti","year":"2003","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bbagen.2008.09.002_bib102","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.diabres.2007.02.004","article-title":"Study of iron metabolism disturbances in an animal model of insulin resistance","volume":"77","author":"Le Guenno","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbagen.2008.09.002_bib103","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0168-8278(98)80011-1","article-title":"End-stage liver disease without hemochromatosis associated with elevated hepatic iron index","volume":"29","author":"Cotler","year":"1998","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib104","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/hep.510300308","article-title":"Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors","volume":"30","author":"Alanen","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/lt.500050109","article-title":"Hereditary hemochromatosis in liver transplantation","volume":"5","author":"Fiel","year":"1999","journal-title":"Liver Transpl. Surg."},{"key":"10.1016\/j.bbagen.2008.09.002_bib106","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/j.1478-3231.2007.01596.x","article-title":"Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry","volume":"27","author":"Ko","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.bbagen.2008.09.002_bib107","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/gast.1996.v110.pm8613000","article-title":"Long-term survival in patients with hereditary hemochromatosis","volume":"110","author":"Niederau","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib108","first-page":"723","article-title":"Onset of hepatocellular carcinoma in a non-cirrhotic patient affected with haemochromatosis","volume":"5","author":"Tomao","year":"1998","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbagen.2008.09.002_bib109","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/00042737-199908000-00019","article-title":"Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature","volume":"11","author":"Goh","year":"1999","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0344-0338(99)80055-7","article-title":"Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report","volume":"195","author":"Kohler","year":"1999","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbagen.2008.09.002_bib111","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/jhep.2000.9033","article-title":"Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases","volume":"32","author":"Bralet","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib112","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/path.1875","article-title":"Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wistar rats fed a diet high in iron","volume":"208","author":"Asare","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib113","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/hmg\/ddm082","article-title":"Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis","volume":"16","author":"Lehmann","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbagen.2008.09.002_bib114","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000012189","article-title":"Interaction between haemochromatosis and transferrin receptor genes in hepatocellular carcinoma","volume":"59","author":"Beckman","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0168-8278(00)80250-0","article-title":"Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver","volume":"32","author":"Blanc","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib116","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1006\/bcmd.2001.0411","article-title":"Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma","volume":"27","author":"Fargion","year":"2001","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbagen.2008.09.002_bib117","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/gut.52.8.1178","article-title":"Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis","volume":"52","author":"Boige","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.bbagen.2008.09.002_bib118","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1542-3565(03)00132-0","article-title":"HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence","volume":"1","author":"Hellerbrand","year":"2003","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib119","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2007.10.038","article-title":"Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis","volume":"134","author":"Nahon","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib120","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1172\/JCI108560","article-title":"An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity","volume":"58","author":"Kushner","year":"1976","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2008.09.002_bib121","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1086\/302119","article-title":"Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles","volume":"63","author":"Mendez","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbagen.2008.09.002_bib122","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/00015550510033688","article-title":"Porphyria cutanea tarda in a Swedish population: risk factors and complications","volume":"85","author":"Rossmann-Ringdahl","year":"2005","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib123","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaad.2004.09.014","article-title":"The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population","volume":"52","author":"Mendez","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib124","first-page":"341","article-title":"Iron metabolism in porphyria cutanea tarda and in erythropoietic protoporphyria","volume":"42","author":"Turnbull","year":"1973","journal-title":"Q. J. Med."},{"key":"10.1016\/j.bbagen.2008.09.002_bib125","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM196812122792402","article-title":"Porphyria cutanea tarda. A study of the effect of phlebotomy","volume":"279","author":"Epstein","year":"1968","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2008.09.002_bib126","first-page":"1","article-title":"The treatment of porphyria cutanea tarda by venesection","volume":"43","author":"Ramsay","year":"1974","journal-title":"Q. J. Med."},{"key":"10.1016\/j.bbagen.2008.09.002_bib127","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0016-5085(85)80084-6","article-title":"Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda","volume":"88","author":"Kushner","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(96)09436-6","article-title":"Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda","volume":"349","author":"Roberts","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2008.09.002_bib129","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0168-8278(98)80313-9","article-title":"The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients","volume":"28","author":"Stuart","year":"1998","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib130","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJM199705013361817","article-title":"Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda","volume":"336","author":"Santos","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2008.09.002_bib131","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/hep.510270627","article-title":"Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America","volume":"27","author":"Bonkovsky","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib132","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood.V95.5.1565.005k42_1565_1571","article-title":"Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda","volume":"95","author":"Bulaj","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2008.09.002_bib133","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1111\/j.1572-0241.2000.03369.x","article-title":"Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection","volume":"95","author":"Martinelli","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib134","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2133.2001.04079.x","article-title":"HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France","volume":"144","author":"Dereure","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004280100401","article-title":"C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients","volume":"439","author":"Tannapfel","year":"2001","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbagen.2008.09.002_bib136","first-page":"853","article-title":"Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent","volume":"48","author":"Hift","year":"2002","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)."},{"key":"10.1016\/j.bbagen.2008.09.002_bib137","first-page":"33","article-title":"Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT)","volume":"48","author":"Lamoril","year":"2002","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)."},{"key":"10.1016\/j.bbagen.2008.09.002_bib138","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000068895","article-title":"Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France","volume":"206","author":"Chiaverini","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib139","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1478-3231.2004.00884.x","article-title":"Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients","volume":"24","author":"Nagy","year":"2004","journal-title":"Liver Int."},{"key":"10.1016\/j.bbagen.2008.09.002_bib140","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1440-1746.2005.03553.x","article-title":"Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda","volume":"20","author":"Gonzalez-Hevilla","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"Suppl 2","key":"10.1016\/j.bbagen.2008.09.002_bib141","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.33549\/physiolres.930000.55.S2.75","article-title":"Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda","volume":"55","author":"Frank","year":"2006","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bbagen.2008.09.002_bib142","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1468-3083.2006.01746.x","article-title":"The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection","volume":"20","author":"Toll","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.bbagen.2008.09.002_bib143","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.510270128","article-title":"High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda","volume":"27","author":"Sampietro","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib144","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/jhep.2001.21409","article-title":"Uroporphyria in Hfe mutant mice given 5-aminolevulinate: a new model of Fe-mediated porphyria cutanea tarda","volume":"33","author":"Sinclair","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/jhep.2003.50034","article-title":"Uroporphyria caused by ethanol in Hfe(\u2212\/\u2212) mice as a model for porphyria cutanea tarda","volume":"37","author":"Sinclair","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib146","first-page":"942","article-title":"Genetic factors influence ethanol-induced uroporphyria in Hfe(\u2212\/\u2212) mice","volume":"40","author":"Gorman","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib147","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1053\/jhep.2002.35621","article-title":"Uroporphyria in the uroporphyrinogen decarboxylase-deficient mouse: interplay with siderosis and polychlorinated biphenyl exposure","volume":"36","author":"Franklin","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2008.09.002_bib148","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1073\/pnas.0700547104","article-title":"A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda","volume":"104","author":"Phillips","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441650800216X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441650800216X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T01:24:50Z","timestamp":1684545890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030441650800216X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":148,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S030441650800216X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2008.09.002","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}